Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Other Non-Current Assets (2017 - 2023)

Updated

Grace Therapeutics (GRCE) reported Other Assets of $23,000 for fiscal Q3 2024 (quarter ended Dec 31, 2023), down 93.5% from $352,000 a year earlier and down 51.1% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Other Non-Current Assets (2017 - 2023) Analysis & Trends

At the end of FY2023 (ended Mar 31, 2023), Grace Therapeutics posted Other Assets of $463,000, up 31.5% from FY2022.

  • Other Assets has a five-year compound annual growth rate of -13.2% (FY2018 to FY2023).
  • By fiscal year, Other Assets came in at $352,000 in FY2022 (-54.2%), $768,000 in FY2021 (+62.4%), $473,000 in FY2020 (-46.4%) and $883,000 in FY2019 (-6.3%).
  • The fiscal Q3 2024 figure ranks as the lowest quarterly Other Assets since fiscal Q3 2019.
  • Year over year, Other Assets has now declined in each of the last three quarters, with an average decline of 48.3% over the last eight quarters.
  • The high point for year-over-year Other Assets in five years was fiscal Q3 2020 (growth of 626.1%); the low point was fiscal Q3 2024 (a decline of 93.5%).
  • Per Business Quant data, the three fiscal quarters before Q3 2024 came in at $47,000 (Q2 2024), $71,000 (Q1 2024) and $463,000 (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 7.70 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 15.10 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 9.42 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 19.90 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 700.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 14.60 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 4.90 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 10.02 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 23,000.00
Sep 30, 2023 47,000.00
Jun 30, 2023 71,000.00
Mar 31, 2023 463,000.00
Dec 31, 2022 352,000.00
Sep 30, 2022 352,000.00
Jun 30, 2022 352,000.00
Mar 31, 2022 352,000.00
Dec 31, 2021 587,000.00
Sep 30, 2021 764,000.00
Jun 30, 2021 392,000.00
Mar 31, 2021 768,000.00
Dec 31, 2020 712,000.00
Sep 30, 2020 680,000.00
Jun 30, 2020 883,000.00
Mar 31, 2020 473,000.00
Dec 31, 2019 138,584.76
Sep 30, 2019 49,112.20
Jun 30, 2019 49,639.92
Mar 31, 2019 877,852.62
API Access

Grace Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=GRCE&period=max&api_key=YOUR_API_KEY